In the News

  • December 29, 2014
  • Haemonetics Sets Date for Third Quarter Fiscal Year 2015 Earnings Release: January 28, 2015
    View details
  • December 22, 2014
  • Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference
    View details
  • November 11, 2014
  • Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference
    View details
  • November 3, 2014
  • Haemonetics Reports 2nd Quarter Fiscal 2015 Revenue of $228 Million and Adjusted EPS of $0.47; Reaffirms Revenue and Earnings Guidance
    View details
  • October 21, 2014
  • Haemonetics exhibits at the 2014 AABB Annual Meeting & CTTXPO
    View details
  • October 6, 2014
  • Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014
    View details
  • August 22, 2014
  • Haemonetics to Present at Morgan Stanley's Global Healthcare Conference
    View details
  • August 5, 2014
  • 2014 SABM-Haemonetics Research Grant Winner
    View details
  • July 30, 2014
  • Haemonetics Reports 1st Quarter Fiscal 2015 Revenue of $224 Million and Adjusted EPS of $0.38, Affirms Full Fiscal Year Guidance
    View details
  • July 23, 2014
  • Charles J. Dockendorff Joins Haemonetics Board of Directors
    View details
  • June 30, 2014
  • Haemonetics Sets Date for First Quarter Fiscal Year 2015 Earnings Release: July 30, 2014
    View details
  • May 28, 2014
  • Haemonetics to Present at the William Blair & Company Growth Stock Conference
    View details
  • May 27, 2014
  • Haemonetics to Present at The Goldman Sachs 35th Annual Global Healthcare Conference
    View details
  • May 23, 2014
  • Haemonetics to Present at The Jefferies 2014 Global Healthcare Conference
    View details
  • April 30, 2014
  • Kent Davies Joins Haemonetics as President, Global Markets
    View details
  • April 28, 2014
  • Haemonetics Authorizes $100 Million Share Repurchase Program
    View details
  • April 28, 2014
  • Haemonetics Reports 4th Quarter Fiscal 2014 Revenue of $241 Million and Adjusted EPS of $0.46; Full Year Revenue of $939 Million, Up 5% and Adjusted EPS of $2.19, Up 10%
    View details
  • April 1, 2014
  • Haemonetics Sets Date for Fourth Quarter and Full Fiscal Year 2014 Earnings Release: April 28, 2014
    View details
  • March 24, 2014
  • Haemonetics Provides Update on U.S. Whole Blood Supply Tender
    View details
  • February 13, 2014
  • Haemonetics to Present at the Raymond James 35th Annual Institutional Investors Conference
    View details
  • February 5, 2014
  • Haemonetics Sets Date for Investor/Analyst Meeting - May 20, 2014
    View details
  • January 27, 2014
  • Haemonetics Reports 3rd Quarter Fiscal 2014 Revenue of $242 Million and $0.61 Adjusted EPS; Extends Multi-Year Agreements With Key Plasma Customers
    View details
  • January 12, 2014
  • Haemonetics Announces Signing of Supply Agreement with HemeXcel at J.P. Morgan Health Care Conference
    View details
  • January 3, 2014
  • Haemonetics Business Update at J.P. Morgan Health Care Conference Will Include Status of U.S. Whole Blood Tenders
    View details
  • January 2, 2014
  • Haemonetics to Present at the 32nd Annual J.P. Morgan Health Care Conference
    View details
  • January 1, 0001
  • Inlog-Website
    View details
View News by Year
UPDATE RESULTS